Pharmascience Inc is proud to announce that it has acquired Uman Pharma Inc. on November 13, 2014.



Portfolio


Pharmascience's Global Injectables Division's  development pipeline is focused primarily on two niche areas in oncology:

 

  • Cytotoxics
  • Advanced formulation


Our portfolio is mainly injectable products which meet specifications laid down by USP and BP. All products are manufactured under strict cGMP standards.

 

In building its portfolio, Pharmascience's Global Injectables Division focuses on products expected to create economic value and that will benefit patients and health professionals.

Portfolio




Pharmascience Inc.

100, de l'Industrie Boulevard, Candiac, Québec, Canada, J5R 1J1

(450) 444-9989 / 1 877 444-9989


Contact us


© 2017 Pharmascience inc. All rights reserved. Website design by Vortex Solution